prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, Clinical Diagnosis and History: Multicentric DCIS and invasive cancer of left breast (mass at. 12:00 and DCIS on core biopsy 9:00) . Specimens Submitted: 1: SP: Sentincl node #1, level 1, left axilla. 2: SP: Sentinel node #2, level 1, left axilla. 3: SP: Sontinel node #3, level 1, left axilla. 4: SP: Sentinel node #4, level 1. left axilla. 5: SP: Non-sentinel node, left axilla. 6: SP: Left total mastectomy (. DIAGNOSIS: 1). LYMPH NODE, SENTINEL #1, LEVEL I, LEFT AXILLA; EXCISION: - ONE BENIGN LYMPK NODE (0/1). - DEEPER LEVEL RECUTS AND SPECIAL STAINS HAVE BEEN ORDERED. THE RESULTS will BE REPORTED IN AN ADDENDUM. 2). LYMPH NODE, SENTINEL #2, LEVEL I, LEFT AXILLA; EXCISION: - ONE BENIGN LYMPH NODE (0/1). - DEEPER LEVEL RECUTS AND SPECIAL STAINS HAVE BEEN ORDERED. THE RESULTS WILL BE REPORTED IN AN ADDENDUM. LYMPH NODE, SENTINEL #3, LEVEL I, LEFT AXILLA; EXCISION: - ONE BENIGN LYMPH NODE (0/1). - DEEPER LEVEL RECUTS AND SPECIAL STAINS HAVE BEEN ORDERED. THE RESULTS WILL BE REPORTED IN AN ADDENDUM. 4). LYMPH NODE, SENTINEL #4. LEFT AXILLA; EXCISION: - ONE BENIGN LYMPH NODE (0/1). - DEEPER LEVEL RECUTS AND SPECIAL STAINS HAVE BEEN ORDERED. THE RESULTS WILL BE REPORTED IN AN ADDENDUM. 5). LYMPH NODE, NON-SENTINEL, LEFT AXILLA; EXCISION: ONE BENIGN LYMPH NODE (0/1). 6). BREAST; LEFT; TOTAL MASTECTOMY: - IN-SITU AND INVASIVE PAPILLARY CARCINCMA. - THE TUMOR MEASURES 3 CM IN GREATEST DIMENSION. SINCE THE. TUMOR GROWS AS LARGE BROAD FRONTS, IT IS NOT POSSIBLE TO. ASSESS THE EXTENT OF INVASION. - DUCTAL CARCINOMA IN-SITU (DCIS) IS ALSO IDENTIFIED,. SOLID/CRIBRIFORM TYPES, WITH INERMEDIATE NUCLEAR GRADE. - THE INVASIVE CARCINOMA IS LOCATED IN THE CENTRAL/ SUPERIOR. 11. AREA. - THE DCIS IS LOCATED IN THE CENTRAL/SUPERIOR AREA AND. MEDIAL ASPECT AT THE PREVIOUS BIOPSY SITE. NO INVOLVEMENT OF THE NIPPLE BY EITHER IN-SITU OR INVASIVE. CARCINOMA IS IDENTIFIED. - CALCIFICATIONS ARE PRESENT IN THE IN-SITU CARCINOMA AND IN. BENIGN BREAST PARENCHYMA. - NO VASCULAR INVASION IS NOTED. INVASIVE CARCINOMA IS 0.3 CM FROM THE NEAREST (SUPERIOR). MARGIN. - DUCTAL CARCINOMA IN-SITU IS 0.3 CH FROK THE NEAREST. (SUPERIOR) MARGIN. NO SKIN INVOLVEMENT BY CARCINOMA IS IDENTIFIED. - THE NON-NEOPLASTIC BREAST TISSUE IS UNREMARIABLE. - THE NON-NEOPLASTIC BREAST TISSUE SHOWS BIOPSY SITE. CHANGES, FIBROCYSTIC CHANGES, BENIGN PAPILLOMAS AND. SCLEROSING ADENOSIS. - RESULTS OF SPECIAL STAINS (ER, PR, HER2-NEU) WILL EE. REPORTED AS AN ADDENDUM. NOTE: DR. BROGI HAS REVIEWED SELECTED SLIDES AND CONCURS. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION. OF THE SLIDES (AND/OR OTHER. MATERIAL) . AND THAT I HAVE REVIEWED AND APPROVED THIS REPORT. Special Studies: stain/Procedure Name. Comment. AE1:AE3. NEGATIVE. KERATIN (CAM5.2). NEGATIVE. NEGATIVE CONTROL. IMMUNO RECUT. NEGATIVE CONTROL. Canceled. IMMUNO RECUT. Canceled. AE1:AE3. NEGATIVE. KERATIN (CAM5.2). NEGATIVE. NEGATIVE CONTROL. IMMUNO RECUT. NEGATIVE CONTROL. IMMUNO RECUT. Canceled. AE1:AE3. NEGATIVE. KERATIN (CAMS.2). NEGATIVE. NEGATIVE CONTROL. IMMUNO RECUT. NEGATIVE CONTROL. Canceled. IMMUNO RECUT. Canceled. AE1:AE3. NEGATIVE. KERATIN (CAMS.2). NEGATIVE. 11. page 3 or b. NEGATIVE CONTROL. IMMUNO RECUT. NEGATIVE CONTROL. Canceled. IMMUNO RECUT. Canceled. ESTROGEN RECEPTOR. POSITIVE. PROGESTERONE RECEPTOR. POSITIVE. HER2-C. NEGATIVE. INTENSITY o. NEGATIVE CONTROL. IMMUNO RECUT. SYNAPTOPHYSIN. CHROMOGRAUNIN. MIB-1 (xi-67). RECUT ADDITIONAL HE. CALPONIN. NEGATIVE CONTROL. Canceled. IMMUNO RECUT. Canceled. NEGATIVE CONTROL. IMMUNO RECUT. NEGATIVE CONTROL FOR HER2. Gross Description: 1). The specimen is received fresh for frozen section. diagnosis, labeled Sentinel node #1, level I, left axilla". It. consists of a lymph node measuring 2 x 1.5 x 0.5 cm. The entire. specimen is submitted in one cassette. Summary of sections: FSC - frozen section control. 2). The specimen is received fresh for frozen section. diagnosis, labeled "Sentinel node #2, level I, left axilla". It. consists of a lymph node measuring 0.7 x 0.7 x 0.4 cm. The. entire specimen is submitted in one cassette. Summary of sections: FSC - frozen section control. 3). The specimen is received frech for frozen section. diagnosis, labeled "Sentinel node #3, level I, left axilla". It. consists of a lymph node measuring 2 x 1.5 x 0.7 cm. The entire. specimen is submitted in one cassette. Summary of sections: FSC - frozen section control. 11. rage  or D. 4). The specimen is received fresh for frozen section. diagnosis, labeled Sentinel node #4, level I, left axilla". It. consists of a lymph node measuring 2.5 x 0.6 x 0.5 cm. The. entire specimen is submitted in one cassette. Summary of sections: FSC - frozen section control. 5). The specimen is received fresh for frozen section. diagnosis, labeled "Non-sentinel node, left axilla. It consists. of a lymph node measuring 2.5 x 1.5 x 0.6 ca. The entire. specimen is submitted in one cassette. Summary of sections: FSC - frozen section control. 6) The specimen is received fresh, labeled "Left Total. Mastectomy, Stitch Marks Axillary Aspect" It consists of. a total mastectory measuring 20. 0 x 15.0 x 6.0 cm. The skin is. brown-black and measures 17.0 x 7.0 cm. Areola nipple complex is. unremarkable and measures 3.5 cm ic diameter. No scars were. grossly identified. The cut sections reveals a mass measuring. 3.0 x 2.5 x 2.0 cm. This macs is located 0.5 em from the. superior margin. This is the closest margin. The cut sections. through the other areas of the breast shows fibrocystic changes. Sections from the lateral upper and lower, medial upper and lower. quadrants are at least 1.0 cm from the closest deep margin. The. tumor is submitted entirely. The reprosentative sections are. also submitted. Summary of Sections: N nipple. TSM - tumor superior margin. T tumor. LL - lateral lower quadrant. LU - lateral upper quadrant. ML - medial lower quadrant. MU - medial upper quadrant. sx skin. Summary of Sections: Part. Sect. Site. Blocks. Pioces. All. 1. FSC. 1. 1. Y. 2. FSC. 1. 1. Y. 3. FSC. 1. Y. 4. FSC. Y. 5. FSC. 1. Y. 6. LL. 2. M. LU. 3. M. ML. 2. M. MU. 2. M. 11. N. 1. M. SK. 1. M. T. 3. M. TSM. 2. M. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the. intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: BENIGN. PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS: BENIGN. PERMANENT DIAGNOSIS: SAME. 3). FROZEN SECTION DIAGNOSIS: BENIGN. PERMANENT DIAGNOSIS: SAME. 4). FROZEN SECTION DIAGNOSIS: BENIGN. PERMANENT DIAGNOSIS: SAME. 5). FROZEN SECTION DIAGNOSIS: BENIGN. PERMANENT DIAGNOSIS: SAME. ADDENDUM: ADDENDUM REPORT. SITE: LEFT BREAST, #6. ER-ICA: POSITIVE. PR-ICA: POSITIVE. HER2/NEU (Hercep Test) : NEGATIVE (STAINING INTENSITY 0). CONTROLS ARE SATISFACTORY. ADDENDUM: ADDENDUM REPORT. 11. SITE: SENTINEL LYMPH NODES, LEFT AXILLA. PARTS #1, 2, 3. 4. ADDITIONAL HE STAINED SECTIONS AND IMMUNOHISTOCHEMICAL STAINS. FOR CYTOKERATINS (AE1:AE3 AND CAM5.2) SHOW NO EVIDENCE OF. METASTATIC TUMOR. ". 11.

expanded version (tokens=2735) : 
 The breast pathology report indicates the following information:

1. Histological Classification:
- Luminal A subtype of breast cancer
- DCIS (ductal carcinoma in situ)
- Invasive papillary carcinoma

2. Subtype:
- Solid/cribriform type of DCIS
- Intermediate nuclear grade

3. Necrosis:
- No mention of necrosis in the report

4. Tumor Infiltrating Lymphocytes (TILs):
- No mention of TILs in the report

5. Histological Grade:
- Not specified in the report

6. Nuclear Grade:
- Intermediate nuclear grade for solid/cribriform type DCIS

7. Lymphovascular Invasion:
- No vascular invasion noted
- Invasive carcinoma is 0.3 cm from the nearest margin

8. Calcification:
- Calcifications are present in the in-situ carcinoma and in benign breast parenchyma

9. Receptor Status:
- Estrogen receptor (ER) - positive
- Progesterone receptor (PR) - positive
- HER2-neu - negative

10. IHC and Other Ancillary Testing Results:
- AE1:AE3, Keratin (CAM5.2), Synaptophysin, Chromogranin, MIB-1, and Calponin tests: negative
- ER-ICA and PR-ICA tests: positive
- Hercep Test for HER2/NEU: negative (st

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2918) : 
 Multicentric ductal carcinoma in situ and invasive papillary carcinoma with calcifications present in the left breast, Luminal A subtype. The tumor measures 3 cm with no vascular invasion and is ER and PR positive, HER2-neu negative. The DCIS is solid/cribriform type with intermediate nuclear grade. No lymphovascular invasion or TILs noted. Sentinel node excisions yielded benign results, but deeper level recuts/stains have yet to be reported. No skin involvement; unremarkable non-neoplastic breast tissue except for biopsy site changes, fibrocystic changes, benign papillomas, and sclerosing adenosis noted.

